Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
Daniel Doheny(Wake Forest University), Hui‐Wen Lo(The University of Texas MD Anderson Cancer Center), Marlyn Anguelov(Wake Forest University), Alexandra Thomas(Cliniques Universitaires Saint-Luc), Austin Arrigo(Wake Forest University), Jiayuh Lin(University of Maryland, Baltimore), Roy E. Strowd(Wake Forest University), Calvin J. Wagner(Wake Forest University), Angelina T. Regua(The University of Texas Health Science Center), Noah R. Aguayo(Wake Forest University), Jimmy Ruiz(Wake Forest University), Michael D. Chan(Wake Forest University), Sherona Sirkisoon(Wake Forest University), Richard L. Carpenter(Indiana University Health), Yu Yang(Shanghai Jiao Tong University), Sara Abu Jalboush(Wake Forest University), Grace L. Wong(Wake Forest University), Sara G. Manore(Wake Forest University)
Cited by 83
Related Papers
Radiation-induced brain injury: A review
|Frontiers in Oncology|2012|686
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|Cancer Cell|2021|330
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients
|Tomography|2015|182
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164